Edwards Lifesciences (EW) Income from Non-Controlling Interests (2023 - 2025)
Edwards Lifesciences' (EW) quarterly Income from Non-Controlling Interests came in at -$0.0 in Q4 2025, up 100.0% year-on-year from -$0.0 in Q4 2024, and up 100.0% quarter-over-quarter from -$800000.0 in Q3 2025.
Edwards Lifesciences (EW) Income from Non-Controlling Interests (2023 - 2025) Analysis & Trends
Edwards Lifesciences' Income from Non-Controlling Interests history runs 3 years deep, the most recent figure standing at -$0.0 for Q4 2025.
- On a quarterly basis, Income from Non-Controlling Interests rose 100.0% year-over-year to -$0.0 in Q4 2025; TTM through Mar 2026 was -$2.5 million, a 55.36% increase from a year earlier, with the FY2025 full-year figure at -$4.1 million, up 16.33% from the prior year.
- Income from Non-Controlling Interests improved to -$0.0 in Q4 2025 per EW's latest filing, from -$800000.0 in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at -$0.0 in Q4 2025 and bottomed at -$1.7 million in Q2 2025.
- The 3-year median for Income from Non-Controlling Interests is -$1.3 million (2024), against an average of -$1.1 million.
- Across the five-year window, Income from Non-Controlling Interests plunged 550.0% in 2024 and soared 100.0% in 2025, its largest moves.
- Year by year, Income from Non-Controlling Interests stood at -$200000.0 in 2023, then plunged by 550.0% to -$1.3 million in 2024, then surged by 100.0% to -$0.0 in 2025.
- Per Business Quant, the three latest EW Income from Non-Controlling Interests figures stand at -$0.0 (Q4 2025), -$800000.0 (Q3 2025), and -$1.7 million (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.52 Bn | 176.22 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.61 Bn | 99.39 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 68.35 Bn | 66.90 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 48.53 Bn | 44.86 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | 22.00 Mn |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.49 Bn | 22.36 Bn | 2.07 Bn | -5.85 Mn |
| 10 | Steris | 21.55 Bn | 21.11 Bn | 697.10 Mn | 100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | -800,000.00 |
| Jun 30, 2025 | -1.70 Mn |
| Mar 31, 2025 | -1.60 Mn |
| Dec 31, 2024 | -1.30 Mn |
| Sep 30, 2024 | -1.40 Mn |
| Jun 30, 2024 | -1.30 Mn |
| Mar 31, 2024 | -900,000.00 |
| Dec 31, 2023 | -200,000.00 |
| Sep 30, 2023 | -1.20 Mn |
| Jun 30, 2023 | -1.60 Mn |